Simultaneous quantification of 24 antiepileptic drugs from plasma or serum by LC-MS/MS for therapeutic drug monitoring.
This comprehensive panel enables simultaneous monitoring of 24 antiepileptic drugs, supporting optimisation of seizure control while minimising adverse effects through individualised dosing.
Clinical indications include:
24 antiepileptic drugs including carbamazepine, oxcarbazepine, lamotrigine, valproic acid, phenytoin, phenobarbital, levetiracetam, topiramate, lacosamide, zonisamide, clobazam, clonazepam, and others.
All 24 drugs are quantified simultaneously by LC-MS/MS from a single plasma or serum sample, using stable isotope internal standards for each analyte. The method provides the specificity necessary to avoid cross-reactivity between structurally similar drugs and their metabolites.
Antiepileptic Drugs is an important biomarker for therapeutic drug monitoring in epilepsy. Masdiag measures antiepileptic drugs using validated analytical methods to provide clinically actionable results.
Antiepileptic Drugs testing is valuable for Therapeutic drug monitoring in epilepsy, Assessment of medication adherence. Understanding antiepileptic drugs levels helps inform personalized health optimization and clinical decision-making.
Antiepileptic Drugs is measured from Plasma / Serum. Professional collection ensures proper sample handling and accurate results.
This test is recommended for individuals interested in therapeutic drug monitoring in epilepsy. Masdiag antiepileptic drugs testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Antiepileptic Drugs results provide insight into your metabolic status and therapeutic drug monitoring in epilepsy. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.